Company

Magnetic Insight, Inc

Imagine advancing tracer imaging beyond the constraints of nuclear medicine and offering a more economical and sustainable solution for diagnosing cancer and heart disease.

At Magnetic Insight, we're pioneering Magnetic Particle Imaging (MPI) — a groundbreaking non-radioactive alternative that can potentially replace over half of nuclear medicine scans and enable entirely new classes of imaging applications. This innovation not only addresses supply vulnerabilities but also enhances the imaging experience for both healthcare professionals and patients. After establishing ourselves as the leading provider of small animal imaging MPI solutions to universities globally, we are now transitioning MPI technology to the clinic.

Join our team as we grow! Visit the Careers page for the latest employment opportunities at Magnetic Insight.

Interested in keeping up with everything MPI? Check out the News page for the latest happenings in the field.

For all other inquiries, contact us here.

Executive Leadership

IMG_9798

Chris A. Raanes

CEO

Bio
Chris A. Raanes
CEO
Mr. Raanes has over twenty years of experience in the medical device sector, having led companies through pivotal stages of growth and commercialization. Previously, he served as Spire Health’s President and Chief Executive Officer, where he supported the commercialization of a wearable sensor for respiratory patients. As President and CEO of ViewRay, he brought the company public on the NASDAQ and led the commercial introduction of the MRIdian, an MRI-guided radiation therapy system. He also held executive positions at Accuray Incorporated and Perkin Elmer Optoelectronics. He holds a B.S. and an M.S. in Electrical Engineering from the Massachusetts Institute of Technology.
patrick[1]

Patrick Goodwill, PhD

Co-founder / CTO

Bio
Patrick Goodwill, PhD
Co-founder / CTO
Dr. Patrick Goodwill, Co-founder and CTO of Magnetic Insight, Inc., has been instrumental in advancing Magnetic Particle Imaging (MPI) technology over nearly two decades. At Magnetic Insight, Dr. Goodwill led the development and commercialization of small animal MPI scanners, establishing the company as the global leader in preclinical MPI. Building on this success, Magnetic Insight is now focused on translating MPI technology to clinical applications. Dr. Goodwill's early work on MPI began during his graduate studies at UC Berkeley and UCSF, where he developed foundational theories and prototypes. He holds a BS and MS in Electrical Engineering from Stanford University and a PhD in Bioengineering from UC Berkeley and UCSF.
BioE_JoanGreve

Joan Greve

Sr. Director, Principal Scientist, Translational Imaging and R&D

Bio
Joan Greve
Sr. Director, Principal Scientist, Translational Imaging and R&D
Dr. Greve joined Magnetic Insight after turns as Program Director at The National Institutes of Health (NIH) and National Cancer Institute (NCI). Prior to that, she served on the biomedical engineering faculty at the University of Michigan and, before joining academia, had a distinguished career at Genentech. Dr. Greve has a PhD in bioengineering and a master's in biomechanical engineering from Stanford University. She received her bachelor's degree in engineering from the University of Washington.

Board of Directors

patrick[1]

Patrick Goodwill, PhD

Co-founder / CTO / CEO

Bio
Patrick Goodwill, PhD
Co-founder / CTO / CEO
Dr. Goodwill has spent the last 9 years leading the development team in Magnetic Particle Imaging at UC Berkeley. In his role, he has designed and built five prototype MPI scanners, and developed the x-space reconstruction systems theory that enables quantitative, high-quality MPI images. Dr. Goodwill has a PhD in Bioengineering from UC Berkeley, and a B.S. and M.S. in Electrical Engineering from Stanford University. Prior to UC Berkeley, Dr. Goodwill designed microprocessors at Intel Corporation.
mike[1]

Mike Harsh

Commercial Advisor- Former, CTO GE Healthcare

Bio
Mike Harsh
Commercial Advisor- Former, CTO GE Healthcare
Mr. Michael (Mike) Harsh is co-founder of Terapede Systems with over 36 years experience in healthcare technology, focused on diagnostic imaging. He served as Vice President and Chief Technology Officer for GE Healthcare, a $17 billion division of General Electric. As the Global Technology Leader of Imaging Technologies at GE Global Research, he led the research for X-Ray, CT, MRI, Ultrasound, Nuclear Medicine, PET and Optical Imaging, and the research associated with computer visualization/image analysis and superconducting systems. Mike was elected to the American Institute for Medical and Biological Engineering (AIMBE) College of Fellows, for his significant contributions to the medical and biological engineering field. Additionally, Mike holds numerous U.S. patents in the field of Medical Imaging and Instrumentation. Mike received a bachelor’s degree in Electrical Engineering from Marquette University, Milwaukee, Wisconsin, and he is a member of the University of Wisconsin Madison Industrial Advisory Board to the College of Engineering.
DGoldman[1]

David Goldman

Celesta

Bio
David Goldman
Celesta
David Goldman is a Partner of Celesta Capital. Prior to joining Celesta, he was an Associate at Paxion Capital, analyzing direct and fund investments across industries. While at Paxion, David took an operational role in the finance org of one of the firm’s portfolio companies helping to raise capital and oversee cash management in Saudi Arabia and the US. David started his career as an Analyst at DBO Partners, where he advised on M&A and capital raises for Semiconductor and Infrastructure Software companies.
JVictor[1]

Joe Victor

CEO of Rarecyte

Bio
Joe Victor
CEO of Rarecyte
Joe Victor Joe Victor, CEO of Rarecyte and serial entrepreneur is on his 3rd company breaking the mold in various areas of life science solutions. He is a seasoned veteran in growing startups into organizations with $100M in revenue.
anna[1]

Anna Christensen, PhD

Co-founder

Bio
Anna Christensen, PhD
Co-founder
Dr Christensen has spent the last 16 years commercializing platform technologies in imaging and diagnostics. Most recently, she led the in vivo imaging business for PerkinElmer Inc and Caliper Life Sciences as the global business leader. Prior to Caliper Life Sciences, she held senior management positions at DiscoverX and Molecular Devices. In addition to her commercial experience, she holds advanced degrees in cell biology and neurobiology from UC San Diego and Copenhagen University.
NBrathwaite[1]

Nicholas Brathwaite

Celesta

Bio
Nicholas Brathwaite
Celesta
Nicholas Brathwaite has spent over 25 years developing technology and building technology-oriented businesses. Before Celesta, Nicholas was also co-founder and partner of private equity firm Riverwood Capital, and from 1996 to 2007, he served as the CTO at Flex, where he oversaw the launch and growth of several of Flex’s largest business units, including an innovative push into product development.

The Advisors

steven[1]

Steven Conolly, PhD

Co-founder, Professor, UC Berkeley

Bio
Steven Conolly, PhD
Co-founder, Professor, UC Berkeley
Prof. Conolly is a the Montford Cook Professor of Bioengineering, Electrical Engineering, and Computer Science at the University of California Berkeley. He received his Ph.D. in Electrical Engineering from Stanford University, where he developed new types of MRI scanners for over twenty years. At Berkeley he has applied his knowledge of building new imaging systems to MPI. He has a history of innovation, and for his many inventions, he was named one of only 24 people named a Stanford Outstanding Inventor.
max[1]

Max Wintermark MD

Medical Advisor, Chief of Neuroradiology, Stanford

Bio
Max Wintermark MD
Medical Advisor, Chief of Neuroradiology, Stanford
Dr. Wintermark is currently a Professor of Radiology and the Chief of Neuroradiology at the Stanford University. His specific interest and expertise is in stroke, traumatic brain injury, epilepsy, movement disorders and psychiatric disorders. He chairs on the research committees for the American Society of Neuroradiology (ASNR), American Society of Functional Neuroradiology (ASFNR) and the imaging working group of the NINDS-funded stroke clinical trial network (StrokeNET).